Small Molecules
14 June 2018
Verseon to Initiate Phase I Study to Evaluate a New Precision Oral Anticoagulant with Reduced Bleeding Risk14 June 2018
Prana to Commence Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian Diseases14 June 2018
Motif Bio Submits NDA for Iclaprim14 June 2018
Flex Pharma Announces Corporate Update13 June 2018
Metacrine Completes Dosing of First Cohort in Phase 1 Trial of MET409, a Novel Non-Bile Acid FXR Agonist11 June 2018
Idorsia initiates a Phase 3 registration program with nemorexant (ACT-541468) for the treatment of insomniaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports